We are live on ! Find out more
RA

RFG Advisory Portfolio holdings

AUM $6.4B
1-Year Est. Return 19.93%
This Fund
S&P 500
This Quarter Est. Return
+12.04%
1 Year Est. Return
+19.93%
3 Year Est. Return
+52.26%
5 Year Est. Return
+48.57%
10 Year Est. Return
+151.03%
AUM
$6.4B
AUM Growth
+$957M
Cap. Flow
+$411M
Cap. Flow %
6.42%
Top 10 Hldgs %
44.31%
Holding
1,200
New
163
Increased
519
Reduced
415
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 5.55%
2 Consumer Discretionary 1.7%
3 Financials 1.58%
4 Communication Services 1.48%
5 Industrials 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLT icon
576
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$1.01M 0.02%
11,733
-20,765
-64% -$1.78M
NLR icon
577
VanEck Uranium + Nuclear Energy ETF
NLR
$3.77B
$1.01M 0.02%
8,687
+2,938
+51% +$392K
HIO
578
Western Asset High Income Opportunity Fund
HIO
$344M
$997K 0.02%
273,827
-13,236
-5% -$48.3K
VRTX icon
579
Vertex Pharmaceuticals
VRTX
$123B
$988K 0.02%
1,989
+324
+19% +$144K
CVS icon
580
CVS Health
CVS
$137B
$985K 0.02%
9,525
-9,471
-50% -$845K
MBB icon
581
iShares MBS ETF
MBB
$39.3B
$978K 0.02%
10,349
-442
-4% -$41.8K
FPEI icon
582
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.92B
$976K 0.02%
50,574
-3,227
-6% -$62.1K
VCR icon
583
Vanguard Consumer Discretionary ETF
VCR
$6.15B
$975K 0.02%
2,457
-512
-17% -$199K
CERY
584
State Street SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF
CERY
$1.08B
$969K 0.02%
29,000
-248
-0.8% -$8.94K
SLYG icon
585
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$5.06B
$965K 0.02%
8,100
+2,849
+54% +$308K
GSK icon
586
GSK
GSK
$104B
$964K 0.02%
18,391
+1,768
+11% +$93.5K
FNOV icon
587
FT Vest US Equity Buffer ETF November
FNOV
$1.2B
$961K 0.02%
16,427
+2,433
+17% +$139K
FAI
588
First Trust Bloomberg Artificial Intelligence ETF
FAI
$151M
$959K 0.02%
+17,622
New +$862K
FSEP icon
589
FT Vest US Equity Buffer ETF September
FSEP
$1.21B
$955K 0.01%
17,344
+1,888
+12% +$102K
VHT icon
590
Vanguard Health Care ETF
VHT
$18B
$953K 0.01%
3,188
+224
+8% +$62.3K
PAVE icon
591
Global X US Infrastructure Development ETF
PAVE
$13.9B
$952K 0.01%
16,150
+32
+0.2% +$1.8K
EMHC icon
592
State Street SPDR Bloomberg Emerging Markets USD Bond ETF
EMHC
$279M
$948K 0.01%
37,269
+271
+0.7% +$6.84K
FFEB icon
593
FT Vest US Equity Buffer ETF February
FFEB
$1.37B
$948K 0.01%
15,546
+1,580
+11% +$94.4K
VIS icon
594
Vanguard Industrials ETF
VIS
$8.12B
$948K 0.01%
2,629
+129
+5% +$43.7K
MNZL
595
Manzil Russell Halal USA Broad Market ETF
MNZL
$21.5M
$944K 0.01%
15,262
-7,399
-33% -$423K
ADM icon
596
Archer Daniels Midland
ADM
$41.4B
$942K 0.01%
12,332
-7,855
-39% -$598K
FAUG icon
597
FT Vest US Equity Buffer ETF August
FAUG
$1.17B
$941K 0.01%
16,650
+2,163
+15% +$119K
TMUS icon
598
T-Mobile US
TMUS
$208B
$939K 0.01%
5,595
+499
+10% +$94.5K
IJK icon
599
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$937K 0.01%
7,975
+249
+3% +$27.7K
COP icon
600
ConocoPhillips
COP
$140B
$934K 0.01%
8,988
+2,886
+47% +$342K

Similar funds

RFG Advisory's Q2 2026 Portfolio in Review

As of Q2 2026, RFG Advisory held 1,200 positions worth $6.4B, up 18% from $5.44B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

RFG Advisory deployed $411M of net new capital in Q2 2026, opening 163 new positions and adding to 519 existing holdings. Its largest new stake was Putnam Focused Large Cap Growth ETF: 264,218 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, up from 4.5% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Invesco S&P International Developed Momentum ETF, an estimated $25.4M trimmed.

  • RFG Advisory's largest Q2 2026 buy was Putnam Focused Large Cap Growth ETF: 264,218 shares worth $12.6M.
  • RFG Advisory added most to Bluemonte Global Equity ETF in Q2 2026, an estimated $79.7M increase.
  • RFG Advisory's biggest Q2 2026 reduction was Invesco S&P International Developed Momentum ETF, cutting an estimated $25.4M.
  • RFG Advisory fully exited BioCryst Pharmaceuticals in Q2 2026, selling an estimated $27.3M.
  • RFG Advisory's ten largest holdings make up 44% of its $6.4B portfolio in Q2 2026.
  • RFG Advisory opened 163 new positions and closed 74 in Q2 2026.
  • RFG Advisory's portfolio value rose 18% quarter-over-quarter to $6.4B.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.